Humana Inc. vs CVS Health Corporation
A head-to-head of Humana Inc. (HUM) and CVS Health Corporation (CVS) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | HUM | CVS |
|---|---|---|
| Market Cap | $48.02B | $137.12B |
| P/E (TTM) | 40.65 | 47.34 |
| Forward P/E | 20.24 | 12.78 |
| P/S | 0.27 | 0.29 |
| P/B | 4.26 | 2.48 |
| EV/EBITDA | 8.85 | 12.05 |
| Dividend Yield | 0.54% | 1.77% |
| Profit Margin | 0.82% | 0.72% |
| Gross Margin | — | 13.77% |
| Operating Margin | — | 2.58% |
| Revenue Growth (YoY) | +23.47% | +6.17% |
| FCF Yield | 3.41% | 6.21% |
| Debt / Equity | 75.05 | 81.29 |
| Current Ratio | 1.77 | 0.87 |
Which is better: Humana Inc. or CVS Health Corporation?
- ✓Larger by market cap: CVS Health Corporation
- ✓Cheaper valuation (lower P/E): Humana Inc.
- ✓Higher dividend yield: CVS Health Corporation
- ✓More profitable (net margin): Humana Inc.
- ✓Faster revenue growth: Humana Inc.
- ✓Higher free-cash-flow yield: CVS Health Corporation
Across 11 available metrics, Humana Inc. leads 7–4.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.